Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia
Open Access
- 1 February 1988
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 57 (2) , 147-156
- https://doi.org/10.1038/bjc.1988.31
Abstract
DBA2 mice were inoculated i.p. with 10(5)L1210 cells. Animals subsequently treated with daunomycin (single i.p. dose, 0.25-5.0 mg kg-1) all died. The maximum increase in mean survival time observed was approximately 135%. Animals treated with N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers conjugated to daunomycin (DNM) showed a significant increase in mean survival time when the polymer-drug linkage was biodegradable (i.e., Gly-Phe-Leu-Gly). Such treatment also produced a number of long term survivors (greater than 50 days). In contrast, HPMA copolymer conjugated to DNM via a non-degradable linkage (Gly-Gly) produced no increase in survival time relative to untreated control animals. The effect observed with biodegradable HPMA copolymer-DNM conjugates was dependent on the concentration of conjugated drug administered (optimum greater than 5 mg kg-1); the frequency of administration (multiple doses were more effective than single); the timing of administration (single doses given on days 1 and 3 were most effective); and the site of tumour inoculation and route of drug administration. Biodegradable HPMA copolymer-DNM conjugates administered i.p. were active against L1210 inoculated s.c. at higher doses than required to curb a peritoneal tumour. Under certain experimental conditions polymer-DNM conjugates containing fucosylamine or galactosamine proved more active than conjugates without the carbohydrate moeity. The mechanism of drug-conjugate action in vivo is at present unclear. Radioiodination of polymer showed approximately 75% of polymer-drug conjugate to be excreted 24 h after i.p. administration. Synthesis of HPMA conjugates containing [3H]DNM showed that polymer containing Gly-Gly-[3H]DNM was excreted (60% of radioactivity in the urine, 24 h) in macromolecular form. In contrast polymer containing Gly-Phe-Leu-Gly-[3H]DNM was largely excreted in the form of low molecular weight species.Keywords
This publication has 30 references indexed in Scilit:
- Effect of molecular weight (Mw) ofN‐(2‐hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to ratsJournal of Biomedical Materials Research, 1987
- Controlled Release of Drug Model from N-(2-Hydroxypropyl)-methacrylamide CopolymersAnnals of the New York Academy of Sciences, 1985
- Tyrosinamide residues enhance pinocytic capture of N-(2-hydroxypropyl)methacrylamide copolymersBiochimica et Biophysica Acta (BBA) - General Subjects, 1984
- Effect of the chemical structure of N- (2- hydroxypropyl) methacrylajnide copolymers on their ability to induce antibody formation in inbred strains of miceBiomaterials, 1984
- Comparison of antitumor effects of daunorubicin covalently linked to poly-l-amino acid carriersEuropean Journal of Cancer and Clinical Oncology, 1984
- Uptake of neoglycoproteins via membrane lectin(s) of L1210 cells evidenced by quantitative flow cytofluorometry and drug targetingBiology of the Cell, 1984
- Cardiotoxicity of Free and Liposomally Encapsulated Rubomycin (Daunorubicin) in MiceOncology, 1984
- Carbohydrate-Specific Receptors of the LiverAnnual Review of Biochemistry, 1982
- Mitomycin C-dextran conjugate: a novel high molecular weight pro-drug of mitomycin CJournal of Pharmacy and Pharmacology, 1980
- DNA—Anthracycline complexes. I. Toxicity in mice and chemotherapeutic activity against L1210 leukemia of daunorubicin—DNA and adriamycin—DNAPublished by Elsevier ,1980